Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 27.31
-0.63 (-2.25%)
Sep 11, 2026, 3:00 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 11.08 billion as of September 11, 2026. Its market cap has increased by 2.61% in one year.
Market Cap
11.08B
Enterprise Value
11.37B
Revenue
759.63M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.31
ChartMarket Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 11.08B, a decrease of -31.48%. That is a compound annual growth rate of -6.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 11.08B | 7.63% |
| Dec 31, 2025 | 10.29B | 139.25% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 13.29B |
| HitGen | 13.00B |
| Shanghai Medicilon | 12.33B |
| Sino Biological,Inc. | 12.12B |
| Inner Mongolia Furui Medical Science | 11.73B |
| Chengzhi | 11.50B |
| Tibet Cheezheng Tibetan Medicine | 11.46B |
| Mabwell (Shanghai) Bioscience | 11.43B |